HIV/AIDS
Findings from S. Sen and co-authors broaden understanding of HIV/AIDS
Published in AIDS Weekly, July 20th, 2009
"The HIV-1 gp41 has been identified as an important target for the immune response, for the development of antiviral and vaccine strategies, and for epidemiologic studies. This study describes the HIV-1 env gp41 region mutations, associated with enfuvirtide (ENF) resistance, in proviral DNA from PBMCs in antiretroviral treatment-naive individuals from Pune, India," scientists writing in the journal AIDS Research and Human Retroviruses report.
"Twenty-one antiretroviral drug-naive chronically HIV-1-infected individuals were enrolled. The study sequences belonged to subtype C (n = 17), subtype A1 (n = 2), and CR_AE (n = 2). In subtype B-infected individuals, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-07-20)
More Articles from AIDS Weekly
- Lifespan
Researchers find possible environmental causes for Alzheimer's, diabetes - University of Texas Health Science Center at Houston
UT School of Public Health researchers develop game for HIV-positive youth - Anal Cancer
Reports summarize anal cancer research from Washington University - Cancer
Scientists at University of Catania describe research in cancer - HIV/AIDS
Recent findings from M.Y. Borget and co-authors highlight research in HIV/AIDS - HIV/AIDS
Recent findings from N. Janin and co-authors highlight research in HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
